Glenmark Pharma (Glenmark Pharmaceuticals) may have become the first Indian company to market a COVID-19 control drug. It received clearance from the government’s drug regulator to market and manufacturer an oral drug that will treat mild to moderate levels of the virus in Covid-19 disease.   However, the government officials and industry watchdogs have also ...

Glenmark Pharma has become the first Indian company to have received clearance from the government’s drug regulator to market and manufacturer an oral drug that will treat mild to moderate levels of the virus in COVID-19 disease.  The anti viral drug is called Favipiravir and will be marketed by the name Fabiflu that will be ...